188 related articles for article (PubMed ID: 30538124)
1. Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
Wu A; Attard G
Clin Chem; 2019 Jan; 65(1):100-107. PubMed ID: 30538124
[TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
3. Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification.
van Dessel LF; Martens JWM; Lolkema MP
Curr Opin Oncol; 2020 Sep; 32(5):527-534. PubMed ID: 32675591
[TBL] [Abstract][Full Text] [Related]
4. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy approach in the management of prostate cancer.
Riaz IB; Wang L; Kohli M
Transl Res; 2018 Nov; 201():60-70. PubMed ID: 29936077
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
7. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice.
Puche-Sanz I; Rodríguez-Martínez A; Garrido-Navas MC; Robles-Fernández I; Vázquez-Alonso F; Álvarez Cubero MJ; Lorente-Acosta JA; Serrano-Fernández MJ; Cózar-Olmo JM
Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):139-147. PubMed ID: 31839360
[TBL] [Abstract][Full Text] [Related]
9. The role of liquid biopsies in prostate cancer management.
Kim CJ; Dong L; Amend SR; Cho YK; Pienta KJ
Lab Chip; 2021 Sep; 21(17):3263-3288. PubMed ID: 34346466
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
Friedlander TW; Welty C; Anantharaman A; Schonhoft JD; Jendrisak A; Lee J; Li P; Hough J; Stromlund A; Edwards M; Sangar S; Kobayashi Y; Simko J; Farrokhian N; Lindquist K; Greene S; Ontiveros P; Graf R; Rodriquez A; Suraneni M; Wang Y; Landers M; Carroll P; Cooperberg MR; Dittamore R; Paris PL
J Urol; 2019 Oct; 202(4):732-741. PubMed ID: 31216253
[TBL] [Abstract][Full Text] [Related]
11. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.
Sperger JM; Emamekhoo H; McKay RR; Stahlfeld CN; Singh A; Chen XE; Kwak L; Gilsdorf CS; Wolfe SK; Wei XX; Silver R; Zhang Z; Morris MJ; Bubley G; Feng FY; Scher HI; Rathkopf D; Dehm SM; Choueiri TK; Halabi S; Armstrong AJ; Wyatt AW; Taplin ME; Zhao SG; Lang JM
J Clin Oncol; 2021 Sep; 39(26):2926-2937. PubMed ID: 34197212
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
González-Billalabeitia E; Conteduca V; Wetterskog D; Jayaram A; Attard G
Prostate Cancer Prostatic Dis; 2019 May; 22(2):195-205. PubMed ID: 30413805
[TBL] [Abstract][Full Text] [Related]
13. Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.
Trujillo B; Wu A; Wetterskog D; Attard G
Br J Cancer; 2022 Nov; 127(8):1394-1402. PubMed ID: 35715640
[TBL] [Abstract][Full Text] [Related]
14. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
15. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
16. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.
Dago AE; Stepansky A; Carlsson A; Luttgen M; Kendall J; Baslan T; Kolatkar A; Wigler M; Bethel K; Gross ME; Hicks J; Kuhn P
PLoS One; 2014; 9(8):e101777. PubMed ID: 25084170
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric liquid biopsy analysis in metastatic prostate cancer.
Hodara E; Morrison G; Cunha A; Zainfeld D; Xu T; Xu Y; Dempsey PW; Pagano PC; Bischoff F; Khurana A; Koo S; Ting M; Cotter PD; Moore MW; Gunn S; Usher J; Rabizadeh S; Danenberg P; Danenberg K; Carpten J; Dorff T; Quinn D; Goldkorn A
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30702443
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.
Parimi S; Ko JJ
Expert Rev Anticancer Ther; 2017 Oct; 17(10):939-949. PubMed ID: 28737470
[TBL] [Abstract][Full Text] [Related]
19. Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Lalonde E; Alkallas R; Chua MLK; Fraser M; Haider S; Meng A; Zheng J; Yao CQ; Picard V; Orain M; Hovington H; Murgic J; Berlin A; Lacombe L; Bergeron A; Fradet Y; Têtu B; Lindberg J; Egevad L; Grönberg H; Ross-Adams H; Lamb AD; Halim S; Dunning MJ; Neal DE; Pintilie M; van der Kwast T; Bristow RG; Boutros PC
Eur Urol; 2017 Jul; 72(1):22-31. PubMed ID: 27815082
[TBL] [Abstract][Full Text] [Related]
20. Exosome-based liquid biopsies in cancer: opportunities and challenges.
Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
